Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 In vivo outcome measures

From: Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia

Study Number of patients Treatment outcome (n. %)
  Included Drop out* Analysed ACPR LTF LPF LCF
AL2002† 55 10(4) 45 32(71.1) 13(28.9) 2(4.4) 11(24.5)
AL2003† 80 6(3) 74 64(86.5) 10(13.5) 6(8.1) 4(5.4)
AM2003‡ 55 3(0) 52 48(92.3) 4(7.7) 3(5.7) 1(2)
AM2004‡ 85 4(1) 81 75(92.6) 6(7.4) 0(0) 6(7.4)
  1. ACPR. Adequate Clinical and Parasitological Response; LTF. Late Treatment Failure;
  2. LCF. Late Clinical Failure; LPF. Late Parasitological Failure; LTF = LCF + LPF.
  3. *Number between parenthesis indicates the number Plasmodium vivax infections
  4. †Artemether 20 mg/kg and lumefantrine 120 mg/kg
  5. ‡Artesunate 12 mg/kg and mefloquine 25 mg/kg
Back to article page